Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for China Tian Yuan Healthcare Group's EV-to-FCF or its related term are showing as below:
HKSE:00557'
s EV-to-FCF Range Over the Past 10 Years
Min: -82.13 Med: -2.38 Max: 80.58
Current: 21.89
During the past 13 years, the highest EV-to-FCF of China Tian Yuan Healthcare Group was 80.58. The lowest was -82.13. And the median was -2.38.
HKSE:00557's EV-to-FCF is ranked worse than 62.45% of 269
companies
in the Credit Services industry
Industry Median: 14.42
vs HKSE:00557: 21.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Tian Yuan Healthcare Group (HKSE:00557) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Tian Yuan Healthcare Group's PE Ratio (TTM) for today is calculated as:
China Tian Yuan Healthcare Group's share price for today is HK$0.545.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Tian Yuan Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.086.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Tian Yuan Healthcare Group EV-to-FCF Related Terms
China Tian Yuan Healthcare Group EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Credit Services subindustry, China Tian Yuan Healthcare Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Tian Yuan Healthcare Group EV-to-FCF vs Credit Services Industry
For the Credit Services industry and Financial Services sector, China Tian Yuan Healthcare Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China Tian Yuan Healthcare Group's EV-to-FCF falls into.
China Tian Yuan Healthcare Group's current Enterprise Value is HK$206.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Tian Yuan Healthcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$9.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Tian Yuan Healthcare Group (HKSE:00557) has a EV-to-FCF of 21.89 as of Aug. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Tian Yuan Healthcare Group and its competitors. According to the industry distribution chart, China Tian Yuan Healthcare Group ranks #168 out of 269 companies in the Credit Services industry, placing it in the top 62.5%.
Is China Tian Yuan Healthcare Group's EV-to-FCF too high?
China Tian Yuan Healthcare Group's current EV-to-FCF is 21.89. The Credit Services industry median EV-to-FCF is 14.42. China Tian Yuan Healthcare Group's value of 21.89 is 51.8% above this industry median. Based on the distribution chart, China Tian Yuan Healthcare Group ranks #168 out of 269 companies in the Credit Services industry, which is below the industry midpoint. Overall, China Tian Yuan Healthcare Group has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Tian Yuan Healthcare Group's EV-to-FCF compare to V and MA?
According to the Credit Services industry distribution chart, China Tian Yuan Healthcare Group ranks #168 out of 269 companies for EV-to-FCF. This places China Tian Yuan Healthcare Group in the lower half of its industry. The industry median EV-to-FCF is 14.42. China Tian Yuan Healthcare Group's value of 21.89 is 51.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Credit Services company?
The median EV-to-FCF among Credit Services companies is 14.42, based on 269 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Tian Yuan Healthcare Group's current EV-to-FCF of 21.89 is 51.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Tian Yuan Healthcare Group and its competitors. For the Credit Services industry, the median EV-to-FCF is 14.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Tian Yuan Healthcare Group's current EV-to-FCF is 21.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Tian Yuan Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, China Tian Yuan Healthcare Group (HKSE:00557) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.32, compared to a current price of HK$0.55 — trading 70.3% above its estimated fair value. The current EV-to-FCF is 21.89 and 51.8% above the Credit Services industry median of 14.42. China Tian Yuan Healthcare Group's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China Tian Yuan Healthcare Group (HKSE:00557), the current EV-to-FCF is 21.89 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Tian Yuan Healthcare Group (HKSE:00557) Overvalued in 2026?
Based on GuruFocus' analysis, China Tian Yuan Healthcare Group stock appears to be overvalued.
The current stock price of HK$0.55 is trading 70.3% above its estimated GF Value™ of HK$0.32.
GuruFocus considers China Tian Yuan Healthcare Group to be Significantly Overvalued.
Key valuation signals for HKSE:00557:
EV-to-FCF: 21.89
GF Value™: HK$0.32 vs. price of HK$0.55 (70.3% above fair value)
Industry Position: 51.8% above the Credit Services median (#168 of 269)
No single metric tells the full story. See the HKSE:00557 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Tian Yuan Healthcare Group Ltd is an investment holding company engaged in investment holding, provision of procurement, marketing and management services to the medical industry, provision of procurement services relating to the hospitality industry, licensing of trademarks, and money lending and related business. Its segments include Investment Holding, Healthcare, Money Lending and Related Business, which generates maximum revenue from interests earned from the provision of loans to third parties, referral and handling fees for loan-related services, and the introduction of prospective lenders and borrowers in PRC and Hong Kong; and Hospitality. The company generates maximum revenue from Hong Kong.
28GF Score
Get the complete analysis for HKSE:00557
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00557 has been successfully added to your 
